NCT03668769

Brief Summary

This trial studies how well a mobile smartphone application called Quitting Schedule works in helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a computer-based initiative that offered state of-the-art smoking cessation treatment and counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for non-patients to find information regarding smoking cessation advice and treatments. Quitting Schedule may help participants to quit smoking.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2017

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2017

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2020

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

2.9 years

First QC Date

September 11, 2018

Last Update Submit

February 22, 2024

Conditions

Cigarette SmokerCurrent Every Day SmokerCurrent SmokerMalignant Neoplasm

Outcome Measures

Primary Outcomes (2)

  • Adaptation of the programmatic infrastructure of WebCASSI (Computer Assisted Stop Smoking Intervention for the World Wide Web) into a more-portable table and smartphone application (app) that will be available both in English and Spanish

    Up to 5 weeks

  • Pre-testing of the app

    A focus group will be used in order to provide feedback on the features of the app in relation to usability for smoking cessation and future app development.

    Up to 5 weeks

Study Arms (1)

Prevention (smoking reduction, Quitting Schedule mobile app)

EXPERIMENTAL

AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule. AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.

Other: Internet Mobile TechnologyOther: InterviewOther: Questionnaire AdministrationBehavioral: Smoking Cessation Intervention

Interventions

Internet Mobile TechnologyOTHER

Use Quitting Schedule mobile smartphone app

Also known as: www-mobile
Prevention (smoking reduction, Quitting Schedule mobile app)
InterviewOTHER

Ancillary studies

Prevention (smoking reduction, Quitting Schedule mobile app)
Questionnaire AdministrationOTHER

Ancillary studies

Prevention (smoking reduction, Quitting Schedule mobile app)
Smoking Cessation InterventionBEHAVIORAL

Participate in individual smoking cessation program

Also known as: Smoking and Tobacco Use Cessation Interventions
Prevention (smoking reduction, Quitting Schedule mobile app)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current smokers (those who smoke at least 5 cigarettes a day; confirmed with carbon monoxide (CO) levels equal or above 7 parts per million ) newly enrolled in the Tobacco Treatment Program at MDACC (Aim 2 )
  • Male or female (Aim 2)
  • Adult cancer patients - 18 years or older (Aim 2)
  • Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at Houston area community services who have smoked at least 100 cigarettes in lifetime
  • Willing to download and use the app Quitting Schedule (Aim 2)
  • Willing to set a quit smoking date within 5 weeks of the enrollment (Aim 2)
  • Ownership of an iPhone or Android smartphone (Aim 2)

You may not qualify if:

  • Unwillingness to participate in the study (Aim 2)
  • Enrolled in another cessation program (Aim 2)
  • Current use of NRT or other smoking cessation medications,e.g. Varenicline or Bupropion outside of the MD Anderson Institution (Aim 2)
  • Expired CO levels below 7ppm (Aim 2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as TopicSmoking Devices

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Paul Cinciripini

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2018

First Posted

September 13, 2018

Study Start

March 27, 2017

Primary Completion

March 4, 2020

Study Completion

March 4, 2020

Last Updated

February 23, 2024

Record last verified: 2024-02